Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Sendi

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
JDR Clinical and Translational Research|April 2, 2019
Health State Utilities in Edentulous Patients: A Time Trade-off ApproachP Sendi, N Oppliger, F Chakroun, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 13, 2005
Dynamics of serum procalcitonin in patients after major neurosurgeryG Laifer, M Wasner, P Sendi, et al.
Infection|April 25, 2009
Broad-range PCR in selected episodes of prosthetic joint infectionF H R De Man, P Graber, M Lüem, et al.
AIDS (London, England)|April 10, 1999
Isoniazid prophylaxis for tuberculosis in HIV infection: a meta-analysis of randomized controlled trialsH C Bucher, L E Griffith, G H Guyatt, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 6, 2005
Genotypic and phenotypic resistance testing of HIV-1 in routine clinical careH H Hirsch, H Drechsler, A Holbro, et al.
The Journal of Hospital Infection|July 19, 2011
Group B streptococcus in prosthetic hip and knee joint-associated infectionsP Sendi, B Christensson, I Uçkay, et al.
AIDS (London, England)|July 9, 1999
Cost effectiveness of highly active antiretroviral therapy in HIV-infected patients. Swiss HIV Cohort StudyP P Sendi, H C Bucher, T Harr, et al.
The Journal of Antimicrobial Chemotherapy|December 11, 1999
Cost-effectiveness of azithromycin for preventing Mycobacterium avium complex infection in HIV-positive patients in the era of highly active antiretroviral therapy. The Swiss HIV Cohort StudyP P Sendi, B A Craig, G Meier, et al.
Diabetologia|February 15, 2000
The cost-effectiveness of different management strategies for type I diabetes: a Swiss perspectiveA J Palmer, C Weiss, P P Sendi, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|August 12, 1999
Rare AIDS-defining diseases in the Swiss HIV Cohort StudyB Burckhardt, P Sendi, D Pfluger, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
JDR Clinical and Translational Research|April 2, 2019
Health State Utilities in Edentulous Patients: A Time Trade-off ApproachP Sendi, N Oppliger, F Chakroun, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 13, 2005
Dynamics of serum procalcitonin in patients after major neurosurgeryG Laifer, M Wasner, P Sendi, et al.
Infection|April 25, 2009
Broad-range PCR in selected episodes of prosthetic joint infectionF H R De Man, P Graber, M Lüem, et al.
AIDS (London, England)|April 10, 1999
Isoniazid prophylaxis for tuberculosis in HIV infection: a meta-analysis of randomized controlled trialsH C Bucher, L E Griffith, G H Guyatt, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 6, 2005
Genotypic and phenotypic resistance testing of HIV-1 in routine clinical careH H Hirsch, H Drechsler, A Holbro, et al.
The Journal of Hospital Infection|July 19, 2011
Group B streptococcus in prosthetic hip and knee joint-associated infectionsP Sendi, B Christensson, I Uçkay, et al.
AIDS (London, England)|July 9, 1999
Cost effectiveness of highly active antiretroviral therapy in HIV-infected patients. Swiss HIV Cohort StudyP P Sendi, H C Bucher, T Harr, et al.
The Journal of Antimicrobial Chemotherapy|December 11, 1999
Cost-effectiveness of azithromycin for preventing Mycobacterium avium complex infection in HIV-positive patients in the era of highly active antiretroviral therapy. The Swiss HIV Cohort StudyP P Sendi, B A Craig, G Meier, et al.
Diabetologia|February 15, 2000
The cost-effectiveness of different management strategies for type I diabetes: a Swiss perspectiveA J Palmer, C Weiss, P P Sendi, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|August 12, 1999
Rare AIDS-defining diseases in the Swiss HIV Cohort StudyB Burckhardt, P Sendi, D Pfluger, et al.
Pageof 6